News IDEXX Laboratories, Inc.

Equities

IDXX

US45168D1046

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-15 pm EDT			5-day change	1st Jan Change
491.3 ^USD	-1.31%		-4.55%	-11.49%

Apr. 01	Elanco Animal Health Appoints Two Ancora Holdings' Nominees to Board	MT
Apr. 01	Elanco appoints two directors after settling with activist Ancora	RE

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

IDEXX Laboratories to Release 2024 First Quarter Financial Results	Apr. 04	BU
Elanco Animal Health Appoints Two Ancora Holdings' Nominees to Board	Apr. 01	MT
Elanco appoints two directors after settling with activist Ancora	Apr. 01	RE
Elanco appoints two directors to its board after agreement with Ancora	Apr. 01	RE
Idexx Laboratories: Superior growth prospects	Mar. 11
Idexx Laboratories Insider Sold Shares Worth $790,427, According to a Recent SEC Filing	Mar. 07	MT
Idexx Laboratories Insider Sold Shares Worth $4,525,596, According to a Recent SEC Filing	Mar. 07	MT
IDEXX Laboratories : Raymond James 45th Annual Institutional Investors Conference presentation	Mar. 04	PU
Transcript : IDEXX Laboratories, Inc. Presents at 45th Annual Raymond James Institutional Investors Conference 2024, Mar-04-2024 11:00 AM	Mar. 04
Ancora seeks four board seats at Elanco amid push for changes	Feb. 29	RE
Transcript : IDEXX Laboratories, Inc. Presents at Bank of America 2024 Animal Health Virtual Summit, Feb-29-2024 10:50 AM	Feb. 29
Ancora seeks four board seats at Elanco amid push for changes, sources say	Feb. 29	RE
IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences	Feb. 20	BU
ANALYST RECOMMENDATIONS : Coinbase, Fortinet, Nike, Chipotle, Nvidia...	Feb. 16
IDEXX Launches Vello™, an Innovative Pet Owner Engagement Software Solution, Streamlining How Practices and Clients Connect	Feb. 15	PR
Idexx Launches Vellotm, an Innovative Pet Owner Engagement Software Solution, Streamlining How Practices and Clients Connect	Feb. 15	CI
Pet products maker Zoetis sees annual profit below estimates on weak demand	Feb. 13	RE
Idexx Laboratories Insider Sold Shares Worth $6,871,319, According to a Recent SEC Filing	Feb. 09	MT
Idexx Laboratories Insider Sold Shares Worth $13,295,975, According to a Recent SEC Filing	Feb. 09	MT
Idexx Laboratories Insider Sold Shares Worth $4,704,559, According to a Recent SEC Filing	Feb. 09	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Idexx Laboratories: Superior growth prospects

March 11, 2024 at 01:18 pm EDT